Latest Stories
3 Reasons VZ is Risky and 1 Stock to Buy Instead
Over the past six months, Verizon’s shares (currently trading at $40.24) have posted a disappointing 8.8% loss, well below the S&P 500’s 13.4% gain. This might have investors contemplating their next move.
Cadre (CDRE): Buy, Sell, or Hold Post Q3 Earnings?
Cadre has had an impressive run over the past six months as its shares have beaten the S&P 500 by 9.8%. The stock now trades at $43.11, marking a 23.1% gain. This performance may have investors wondering how to approach the situation.
3 Reasons to Avoid EPC and 1 Stock to Buy Instead
What a brutal six months it’s been for Edgewell Personal Care. The stock has dropped 37.2% and now trades at $16.43, rattling many shareholders. This was partly due to its softer quarterly results and may have investors wondering how to approach the situation.
3 Reasons to Sell LOCO and 1 Stock to Buy Instead
El Pollo Loco has been treading water for the past six months, recording a small return of 3.7% while holding steady at $11.33. The stock also fell short of the S&P 500’s 13.4% gain during that period.
3 Reasons to Sell TFC and 1 Stock to Buy Instead
Truist Financial trades at $47.70 and has moved in lockstep with the market. Its shares have returned 17.1% over the last six months while the S&P 500 has gained 13.4%.
3 Reasons to Avoid DOX and 1 Stock to Buy Instead
Over the last six months, Amdocs’s shares have sunk to $77.15, producing a disappointing 17.3% loss - a stark contrast to the S&P 500’s 13.4% gain. This may have investors wondering how to approach the situation.
3 Reasons to Avoid PFBC and 1 Stock to Buy Instead
Preferred Bank has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 11% to $94.70 per share while the index has gained 13.4%.
First Bancorp (FBNC): Buy, Sell, or Hold Post Q2 Earnings?
First Bancorp has had an impressive run over the past six months as its shares have beaten the S&P 500 by 7.7%. The stock now trades at $51.20, marking a 21% gain. This performance may have investors wondering how to approach the situation.
3 Reasons PMT is Risky and 1 Stock to Buy Instead
PennyMac Mortgage Investment Trust has been treading water for the past six months, recording a small loss of 1.2% while holding steady at $12.58. The stock also fell short of the S&P 500’s 13.4% gain during that period.
Q3 Earnings Outperformers: Teleflex (NYSE:TFX) And The Rest Of The Surgical Equipment & Consumables - Specialty Stocks
As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the surgical equipment & consumables - specialty industry, including Teleflex (NYSE:TFX) and its peers.